October 18, 2011
Currently AVAILABLE Therapies for Relapsing forms of Multiple Sclerosis
- /
- /
Approved therapies to treat RRMS COPAXONE®: A unique RRMS therapy thought to modify the immune response by helping to restore…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
October 17, 2011
Novartis drug Gilenya® (fingolimod) has more than 20,000 patient-years of exposure and shows up to 71% reduction in annualized relapse rates in MS patients with highly active disease
- /
Mon Oct 17, 2011 1:15am EDT Novartis International AG / Novartis drug Gilenya® (fingolimod) has more than 20,000 patient-years of…
October 17, 2011
Shift Work / Night Work, May Put Teens at Risk for Multiple Sclerosis
- /
- /
MONDAY, Oct. 17 (HealthDay News) — Working overnight or odd shifts may increase teenagers’ risk of developing multiple sclerosis, according to…
October 17, 2011
Stem Cells a Step Forward for Treating M.S., Other Diseases
- /
- /
- /
Areas in red indicate mouse brain cells coated with myelin, a crucial substance lacking in patients with M.S. Scientists have…
October 16, 2011
Researchers Recruiting 5,000 First-Degree Relatives of People with MS for Genetic/Environmental Research Study
- /
- /
LARGE GENETIC RESEARCH study for relatives of MS Patients A group of researchers at Harvard Medical School, Brigham and Women’s…
October 13, 2011
From New Zealand, an MS Patient describes his MASSIVE Improvement
- /
An MS Patient wishes to inform the world how his life with debilitating Multiple Sclerosis has improved Click the links…
October 13, 2011
Current MS Medications Previously Approved and Medications under review or in research
- /
- /
Source: MS Association of America FDA-Approved Medications Avonex® (interferon beta-1a) Betaseron® (interferon beta-1b) Extavia® (interferon beta-1b) Rebif® (interferon beta-1a) Copaxone®…
October 11, 2011
Natalizumab (Tysabri) Effective for Relapsing-Remitting MS
- /
- /
- /
Natalizumab is well tolerated and reduces relapses and disability at two years in patients with relapsing-remitting multiple sclerosis, according to…
October 11, 2011
Reduced Loss of Brain Volume in Multiple Sclerosis Patients Treated with COPAXONE®
- /
Five-year Study Findings Published in the Journal of the Neurological Sciences JERUSALEM, Israel–Results from a five-year study of treatment-naïve patients with…
October 11, 2011
APPLYING for Social Security Disability Now might be a wee bit easier
- /
- /
SocialSecurityDisability.tv is an informational website on Social Security Disability Benefits. It contains information on how to qualify and apply for…
